1. Home
  2. RBKB vs KPTI Comparison

RBKB vs KPTI Comparison

Compare RBKB & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBKB

Rhinebeck Bancorp Inc.

HOLD

Current Price

$15.59

Market Cap

171.6M

Sector

Finance

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.01

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
KPTI
Founded
1860
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.6M
172.6M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
RBKB
KPTI
Price
$15.59
$8.01
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$14.67
AVG Volume (30 Days)
9.3K
1.3M
Earning Date
04-24-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
215.00
N/A
EPS
0.92
N/A
Revenue
$2,984,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.36
P/E Ratio
$16.88
N/A
Revenue Growth
N/A
0.57
52 Week Low
$9.41
$3.65
52 Week High
$16.50
$10.99

Technical Indicators

Market Signals
Indicator
RBKB
KPTI
Relative Strength Index (RSI) 55.34 58.78
Support Level $15.04 $5.43
Resistance Level $16.50 $9.00
Average True Range (ATR) 0.26 0.71
MACD -0.04 0.28
Stochastic Oscillator 55.13 93.23

Price Performance

Historical Comparison
RBKB
KPTI

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: